EDSA - Edesa Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/29/2018
9/29/2017
9/29/2016
Total Revenue
298
212
228
1,272
Cost of Revenue
410
445
534
1,128
Gross Profit
-112
-233
-306
144
Operating Expenses
Research Development
1,809
2,087
1,973
1,729
Selling General and Administrative
3,513
2,757
2,945
3,323
Total Operating Expenses
5,322
4,845
4,918
5,052
Operating Income or Loss
-5,434
-5,078
-5,225
-4,908
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
87
40
195
-111
Income Before Tax
-5,347
-5,038
-5,030
-5,019
Income Tax Expense
1
1
1
7
Income from Continuing Operations
-5,348
-5,039
-5,031
-5,026
Net Income
-5,348
-5,039
-5,031
-5,026
Net Income available to common shareholders
-5,348
-5,039
-5,031
-5,026
Reported EPS
Basic
-
-10.56
-20.58
-23.94
Diluted
-
-10.56
-20.58
-23.94
Weighted average shares outstanding
Basic
-
478
244
210
Diluted
-
478
244
210
EBITDA
-
-4,890
-5,045
-4,759